Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Bibliographic Details
Main Authors:	Xiaoshan Zhou, Haoran Dai, Hanxue Jiang, Hongliang Rui, Wenbin Liu, Zhaocheng Dong, Na Zhang, Qihan Zhao, Zhendong Feng, Yuehong Hu, Fanyu Hou, Yang Zheng, Baoli Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Pharmacology
Subjects:	PM2.5 PLA2R1 microRNA Th17/Treg primary membranous nephropathy (PMN)
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1166591/full

Similar Items

MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
by: Xiaoshan Zhou, et al.
Published: (2022-09-01)

Experimental models for elderly patients with membranous nephropathy: Application and advancements
by: Xinyue Tang, et al.
Published: (2024-01-01)

The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification
by: Xiaofan Hu, et al.
Published: (2023-12-01)

Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time
by: Na Zhang, et al.
Published: (2022-08-01)

Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage
by: Qihan Zhao, et al.
Published: (2024-05-01)

Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis
by: Zhaocheng Dong, et al.
Published: (2022-01-01)

Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial
by: Naiqian Zhang, et al.
Published: (2024-12-01)

The Ameliorative Effect of Mahuang Fuzi and Shenzhuo Decoction on Membranous Nephropathy of Rodent Model is Associated With Autophagy and Wnt/β-Catenin Pathway
by: Yu Gao, et al.
Published: (2022-04-01)

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
by: Wenbin Liu, et al.
Published: (2019-08-01)

Do natural Treg become activated to antigen specific Treg in transplantation and in autoimmunity?
by: Bruce Milne Hall, et al.
Published: (2013-08-01)

Guominkang formula alleviate inflammation in eosinophilic asthma by regulating immune balance of Th1/2 and Treg/Th17 cells
by: Yumei Zhou, et al.
Published: (2022-10-01)

Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity
by: Andrzej Chruscinski, et al.
Published: (2015-07-01)

Bee Venom Phospholipase A2 Ameliorates Atherosclerosis by Modulating Regulatory T Cells
by: Geun-Hyung Kang, et al.
Published: (2020-09-01)

The ST2+ Treg/amphiregulin axis protects from immune-mediated hepatitis
by: Selina Wachtendorf, et al.
Published: (2024-03-01)

TNFR2: The new Treg switch?
by: José L. Cohen, et al.
Published: (2018-01-01)

Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues
by: Kai Yang, et al.
Published: (2022-06-01)

Anti-Inflammatory and Anti-asthmatic Effects of TMDCT Decoction in Eosinophilic Asthma Through Treg/Th17 Balance
by: Yumei Zhou, et al.
Published: (2022-02-01)

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
by: Tianhui An, et al.
Published: (2023-01-01)

How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
by: Zhendong Feng, et al.
Published: (2020-07-01)

Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer
by: Lili Huang, et al.
Published: (2023-12-01)

Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs
by: Huiyun Lyu, et al.
Published: (2023-12-01)

Dielectric properties of ceramics in lead zirconate titanate - lead magnesium niobate system
by: Pitak Laoratakul, et al.
Published: (2004-05-01)

The immunomodulation role of Th17 and Treg in renal transplantation
by: Dan-Lei Huang, et al.
Published: (2023-02-01)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
by: Yang Chen, et al.
Published: (2023-12-01)

Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
by: Aazam Ghelani, et al.
Published: (2020-06-01)

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy
by: Yang Yang, et al.
Published: (2023-03-01)

The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection
by: Zhan Xu, et al.
Published: (2022-07-01)

Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis
by: Rui Zhang, et al.
Published: (2022-05-01)

Treg Enhancing Therapies to Treat Autoimmune Diseases
by: Peter J. Eggenhuizen, et al.
Published: (2020-09-01)

Adenosine and Prostaglandin E2 Production by Human Inducible Regulatory T cells (iTreg) in Health and Disease
by: Theresa L Whiteside, et al.
Published: (2013-07-01)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
by: Yuemeng Sun, et al.
Published: (2022-12-01)

Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
by: Serena De Matteis, et al.
Published: (2018-06-01)

Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development
by: Yuetao Zhou, et al.
Published: (2016-08-01)

Editorial: Inflammatory Treg reprogramming in the tumor immune microenvironment
by: Xinpei Deng, et al.
Published: (2024-04-01)

Genetic determinants of the development and course of membranous nephropathy
by: E S Kamyshova, et al.
Published: (2018-06-01)

Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice
by: Xiangli Zhao, et al.
Published: (2021-10-01)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
by: Motahareh Arjomandnejad, et al.
Published: (2022-01-01)

Studying the Frequency Ratio of Treg/Th1 and Treg/Th2 Lymphocytes in Hodgkin\'s Lymphoma Patients and its Relationship with Disease Prognosis
by: N Arandi, et al.
Published: (2022-12-01)

Studying the Frequency Ratio of Treg/Th1 and Treg/Th2 Lymphocytes in Hodgkin\'s Lymphoma Patients and its Relationship with Disease Prognosis
by: N Arandi, et al.
Published: (2023-03-01)

Posttransplant membranous nephropathy - A case report
by: Shabna Sullaiman, et al.
Published: (2022-01-01)